BofA analyst Tim Anderson raised the firm’s price target on Eli Lilly (LLY) to $1,000 from $997 and keeps a Buy rating on the shares after ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

In a report released yesterday, Mark Lipacis from Evercore ISI maintained a Hold rating on Qualcomm (QCOM – Research Report), with a price ...

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a ...

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...

U.S. stock futures are edging mostly higher as investors watch corporate earnings, Honeywell plans to split into three companies, and Qualcomm stock drops as its licensing revenue misses expectations.

US stock futures steadied Thursday, as investors focused on more corporate earnings ahead of key payrolls data at the end of ...

Among early movers, U.S.-listed shares of Arm Holdings (NASDAQ: ARM) dropped 3.8% after the chip-tech provider topped current-quarter expectations, but said it would no longer meet the top end of its ...

Trump’s trade war, U.S. jobs report, and more ‘Big Tech’ earnings will be in focus this week. • Amazon looks set to deliver ...

QUALCOMM (NASDAQ:QCOM – Get Free Report) is projected to post its quarterly earnings results after the market closes on ...

Minnesota Attorney General Keith Ellison announced on Monday that a settlement has been reached Novo Nordisk over the high ...